PHARMACY

Lupin launches generic Gleevec
Imatinib mesylate tablets had a market value of about $548 million, according to IQVIA May 2019 data.
Karyopharm Therapeutics gets FDA OK for Xpovio
Karyopharm Therapeutics' Xpovio provides a treatment option for patients with multiple myeloma that has no available therapy.

Lannett to distribute levothyroxine sodium

Lannett will distribute Cediprof's levothyroxine sodium tablets no later than Aug. 1, 2022.
Perrigo gets FDA nod for generic Metrogel-Vaginal gel

MetroGel-Vaginal had a market value of about $100 million for the 12 months ending May 2019, according to IQVIA.
Dr. Reddy’s launches first generic Hemabate injection

The Hemabate brand had a market value of approximately $55 million for the most recent 12 months ended April 2019, according to IQVIA.
DisposeRx inks agreement with VA to offer at-home drug disposal

Veterans will be able to dispose of unused medication via DisposeRx's medication disposal solution.
CVS Health praises Hawaii for prescription drug take-back programs

Seventeen in-store drug disposal units will be installed in select Longs Drugs locations in July to provide community access to safe disposal of unwanted medications as Hawaii enacts a law enabling their availability.
Upsher-Smith to commercialize Klor-Con and potassium chloride products

Upsher-Smith Laboratories will commercialize and continue to manufacture Klor-Con (potassium chloride) and potassium chloride product families.
Sandoz offers free Symjepi to Americares for low-income and uninsured patients

Sandoz has donated more than 4,000 packs (more than 8,000 individual injections) of its Symjepi (epinephrine 0.3 mg) injectable medication to Americares for free distribution.
Albertsons pharmacy technicians first in Idaho trained to prescribe naloxone

As a new Idaho law allowing pharmacy technicians to prescribe naloxone takes effect, Albertsons announced that its Boise-area pharmacy technicians are the first in the state who have been trained to do so.